GetTopicDetailResponse(id=dec1648e41a, topicName=法舒地爾, introduction=法舒地爾, content=null, image=null, comments=1, allHits=1362, url=https://h5.medsci.cn/topic?id=64874, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=102498, tagList=[TagDto(tagId=102498, tagName=法舒地爾)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2238182, encodeId=cf7f223818202, content=<a href='/topic/show?id=eb418106018' target=_blank style='color:#2F92EE;'>#肌萎縮側(cè)索硬化癥#</a> <a href='/topic/show?id=dec1648e41a' target=_blank style='color:#2F92EE;'>#法舒地爾#</a>, objectTitle=《柳葉刀·神經(jīng)病學(xué)》：法舒地爾在肌萎縮側(cè)索硬化癥中的安全性、耐受性和有效性研究, objectType=article, longId=851916, objectId=9fa0851916e0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241120/1732067479023_8538692.jpg, objectUrl=/article/show_article.do?id=9fa0851916e0, replyNumber=0, likeNumber=49, createdTime=2024-11-21, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=9fa0851916e0, moduleTitle=《柳葉刀·神經(jīng)病學(xué)》：法舒地爾在肌萎縮側(cè)索硬化癥中的安全性、耐受性和有效性研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9fa0851916e0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2235525, encodeId=c4a8223552591, content=<a href='/topic/show?id=eb418106018' target=_blank style='color:#2F92EE;'>#肌萎縮側(cè)索硬化癥#</a> <a href='/topic/show?id=dec1648e41a' target=_blank style='color:#2F92EE;'>#法舒地爾#</a>, objectTitle=《The Lancet Neurology》：法舒地爾治療肌萎縮側(cè)索硬化癥的安全性、耐受性和療效研究, objectType=article, longId=850164, objectId=c7a8850164bd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240729/1722218606037_8538692.png, objectUrl=/article/show_article.do?id=c7a8850164bd, replyNumber=0, likeNumber=65, createdTime=2024-11-06, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c7a8850164bd, moduleTitle=《The Lancet Neurology》：法舒地爾治療肌萎縮側(cè)索硬化癥的安全性、耐受性和療效研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c7a8850164bd)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2176996, encodeId=25d221e6996e6, content=<a href='/topic/show?id=0bad820e112' target=_blank style='color:#2F92EE;'>#肺動(dòng)脈高壓#</a> <a href='/topic/show?id=dec1648e41a' target=_blank style='color:#2F92EE;'>#法舒地爾#</a>, objectTitle=Pharmaceuticals (Basel) ：氣管內(nèi)使用含有法舒地爾和/或 DETA NONOate 的肽修飾脂質(zhì)混合物可改善肺動(dòng)脈高壓的各種病理學(xué), objectType=article, longId=806782, objectId=f1b6806e82bb, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867287231_4754896.png, objectUrl=/article/show_article.do?id=f1b6806e82bb, replyNumber=0, likeNumber=90, createdTime=2023-12-25, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f1b6806e82bb, moduleTitle=Pharmaceuticals (Basel) ：氣管內(nèi)使用含有法舒地爾和/或 DETA NONOate 的肽修飾脂質(zhì)混合物可改善肺動(dòng)脈高壓的各種病理學(xué), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f1b6806e82bb)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1986198, encodeId=37b4198619842, content=<a href='/topic/show?id=dec1648e41a' target=_blank style='color:#2F92EE;'>#法舒地爾#</a>, objectTitle=Congenit Heart Dis：法舒地爾可以改善CHD-PAH患者的血流動(dòng)力學(xué)，特別是60-mg劑量, objectType=article, longId=192115, objectId=ffc4192115cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffc4192115cf, replyNumber=0, likeNumber=84, createdTime=2020-04-22, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffc4192115cf, moduleTitle=Congenit Heart Dis：法舒地爾可以改善CHD-PAH患者的血流動(dòng)力學(xué)，特別是60-mg劑量, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ffc4192115cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
